16.56% 0.245

Inmed Pharmaceuticals Inc (INM)

Panoramica Notizia Cronologia dei prezzi Financials Forum Previsione Frazionamento azionario

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Inmed Pharmaceuticals Inc Stock (INM) Company Profile

Inmed Pharmaceuticals Inc

Healthcare (1083)

(604) 669-7207

1445-885 WEST GEORGIA ST., VANCOUVER

Prossima data di guadagno

Ultimi documenti SEC

INM's Discussions on Twitter

Compare INM vs TAK, HLN, TEVA, ZTS, UTHR

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
INM Inmed Pharmaceuticals Inc	1.785	8.12M	3.25M	-8.34M	-7.71M	-2.5755
TAK Takeda Pharmaceutical Co Adr	16.98	54.45B	29.91B	1.30B	3.49B	0.4056
HLN Haleon Plc Adr	9.885	44.21B	14.54B	2.22B	2.58B	0.4871
TEVA Teva Pharmaceutical Industries Ltd Adr	30.54	36.10B	17.53B	1.58B	444.18M	1.3457
ZTS Zoetis Inc	74.24	31.95B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	529.18	26.36B	3.17B	1.29B	1.01B	27.09

Inmed Pharmaceuticals Inc Borsa (INM) Ultime notizie

Inmed Pharmaceuticals Inc Azioni (INM) Dati Finanziari

Inmed Pharmaceuticals Inc Azioni (INM) insider trading

Commercio interno	Relazione	Data	Transazione	Costo	#Azioni	Valore ($)	#Azioni Totale
Vivo Opportunity, LLC	10% Owner	Jul 15 '26	Buy	1.55	15,150	23,482	743,038
Vivo Opportunity, LLC	10% Owner	Jul 14 '26	Buy	1.55	5,375	8,331	729,277
Vivo Opportunity, LLC	10% Owner	Jul 16 '26	Buy	1.55	21	33	743,057
Vivo Opportunity, LLC	10% Owner	Jul 01 '26	Buy	1.55	4,344	6,733	722,935
Vivo Opportunity, LLC	10% Owner	Jul 02 '26	Buy	1.55	1,607	2,491	724,395
Vivo Opportunity, LLC	10% Owner	Jun 30 '26	Buy	1.54	600	924	718,989
Vivo Opportunity, LLC	10% Owner	May 20 '26	Buy	1.56	56,210	87,688	543,129
Vivo Opportunity, LLC	10% Owner	Jun 05 '26	Buy	1.57	55,011	86,367	688,926
Vivo Opportunity, LLC	10% Owner	May 21 '26	Buy	1.69	34,000	57,460	574,011
Vivo Opportunity, LLC	10% Owner	Jun 08 '26	Buy	1.52	32,500	49,400	718,444

Inmed Pharmaceuticals Inc (INM)

Inmed Pharmaceuticals Inc Stock (INM) Company Profile

Compare INM vs TAK, HLN, TEVA, ZTS, UTHR

Inmed Pharmaceuticals Inc Borsa (INM) Ultime notizie

Morning Market Movers: INM, INLF, SXTC, ADVB See Big Swings - RTTNews

12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga

Mentari Therapeutics Announces $200 Million Private Placement for Migraine Prevention Pipeline - TradingView

InMed (NASDAQ: INM) outlines Mentari merger structure and names new CEO - Stock Titan

InMed Pharmaceuticals (INM) Gains 1.3% as Stock Approaches Key Resistance LevelForce Index - dars.gov.et

ADAR1 Capital acquires 1,000 InMed common shares worth $1,555 - Bitget

InMed Pharmaceuticals (INM) holder buys 1,000 common shares via ADAR1 - Stock Titan

Vivo Opportunity reports USD 32,319 purchase of InMed common shares - Bitget

Vivo Opportunity funds add 20,546 InMed Pharmaceuticals (INM) shares - Stock Titan

InMed Pharmaceuticals Inc (NASDAQ: INM) Share Price, INM Stock News, INM Share Price & Updates - Kalkine

InMed Pharmaceuticals(INM) Stock Options Chain | Quotes & News - Moomoo

InMed Pharmaceuticals Company Profile & Introduction - Moomoo

InMed Pharmaceuticals and Mentari Therapeutics Amend Merger Agreement and File Registration Statement for Migraine Therapy Deal 1 – Minichart - Minichart

12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga

InMed amends merger terms, advances Mentari transition - TipRanks

InMed Pharmaceuticals (Nasdaq: INM) refines structure of planned Mentari merger - Stock Titan

InMed Pharmaceuticals Updates Mentari Merger Terms, Adding PIPE Option and Confirming Tax Reorganization - TradingView

InMed Pharmaceuticals (NASDAQ: INM) clarifies Mentari merger structure and targets Q4 2026 closing - Stock Titan

Enterprise value to EBIT forward of InMed Pharmaceuticals Inc. – NASDAQ:INM - TradingView

InMed Pharmaceuticals Amends Deal With Mentari Therapeutics - Moomoo

InMed Pharmaceuticals (INM) Moves Forward with Merger Agreement Amendments - GuruFocus

InMed Pharmaceuticals and Mentari Therapeutics Announce Amendment to Merger Agreement and Filing of Registration Statement on Form S-4 - TMX Newsfile

InMed Pharmaceuticals (INM) Stages 7% Advance: Testing Key Resistance LevelPut Dominated - DonanımHaber

InMed Pharmaceuticals (INM) Slips 1.89% as Shares Test Key Support at $1.48Counter Trend Trade - dars.gov.et

INMInMed Pharmaceuticals Inc Forecast, Target Price - Finviz

Vivo Opportunity increases InMed (INM) stake with open-market share buys - Stock Titan

InMed (INM) to merge with Mentari after $290M financing; Exchange ~2.0606 - Stock Titan

InMed Pharmaceuticals (INM) Q3 2025 Earnings: Continued R&D Progress Amid No RevenueEnergy Earnings Report - DonanımHaber

Price to sales forward of InMed Pharmaceuticals Inc. – NASDAQ:INM - TradingView

Price to earnings forward of InMed Pharmaceuticals Inc. – NASDAQ:INM - TradingView

Enterprise value to revenue forward of InMed Pharmaceuticals Inc. – NASDAQ:INM - TradingView

Penny stock InMed Pharmaceuticals merger deal targets migraine pipeline - MSN

InMed Pharmaceuticals Inc. Actuals & Estimates (NASDAQ:INM) - TradingView

InMed Pharmaceuticals Inc (INM) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

InMed Pharmaceuticals Inc (INM) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

InMed Pharmaceuticals Inc. Cash Flow – DUS:MWG - TradingView

Dilution adjustment of InMed Pharmaceuticals Inc. – DUS:MWG - TradingView

Current ratio of InMed Pharmaceuticals Inc. – DUS:MWG - TradingView

Total revenue of InMed Pharmaceuticals Inc. – DUS:MWG - TradingView

Basic earnings per share (basic EPS) of InMed Pharmaceuticals Inc. – DUS:MWG - TradingView

MWG Stock Price and Chart — DUS:MWG - TradingView

InMed Pharmaceuticals Inc (INM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

InMed Pharmaceuticals Inc (INM) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

InMed Pharmaceuticals Inc (INM) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

InMed Pharmaceuticals Inc (INM) Valuation: PE, PB & Fair Value Analysis - TradingKey

InMed Pharmaceuticals Inc (INM) Institutional Confidence - TradingKey

InMed Pharmaceuticals Inc (INM) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

InMed Pharmaceuticals Inc (INM) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Moderna to Host Investor EventScience Day - Investing News Network

InMed Pharmaceuticals (INM) Slides to $1.5 as Traders Eye Support at $1.42RTH Profile - dars.gov.et

Inmed Pharmaceuticals Inc Azioni (INM) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Inmed Pharmaceuticals Inc Azioni (INM) insider trading

Simile a INM